The incidence and risk factors of de novo skin cancer in the liver transplant recipients.

PubWeight™: 0.75‹?›

🔗 View Article (PMC 4089301)

Published in Int J Organ Transplant Med on January 01, 2012


J Modaresi Esfeh1, I A Hanouneh2, D Dalal3, A Tabba2, R Lopez3, M Pagadala2, B Eghtesad4, N N Zein2

Author Affiliations

1: Department of Internal Medicine.
2: Department of Gastroenterology and Hepatology.
3: Department of Quantitative Health Sciences.
4: Department of General Surgery, Transplant Center, The Cleveland Clinic, Cleveland, Ohio, USA.

Articles cited by this

Cutaneous manifestations of immunosuppression in organ transplant recipients. J Am Acad Dermatol (1989) 1.48

The changing pattern of posttransplant malignancies. Transplant Proc (1991) 1.42

De novo malignancies after liver transplantation: a major cause of late death. Liver Transpl (2001) 1.30

Risk factors and incidence of de novo malignancy in liver transplant recipients: a systematic review. Liver Int (2010) 1.14

Liver transplant recipients older than 60 years have lower survival and higher incidence of malignancy. Am J Transplant (2003) 1.13

De novo internal neoplasms after liver transplantation: increased risk and aggressive behavior in recent years? Am J Transplant (2004) 1.09

De novo malignancies after liver transplantation using tacrolimus-based protocols or cyclosporine-based quadruple immunosuppression with an interleukin-2 receptor antibody or antithymocyte globulin. Cancer (1997) 1.06

Increased incidence of oropharyngeal squamous cell carcinomas after liver transplantation for alcoholic cirrhosis. Transplantation (1999) 1.05

Skin cancer in kidney and heart transplant recipients and different long-term immunosuppressive therapy regimens. J Am Acad Dermatol (2000) 1.04

Skin cancer and immunosuppression. Crit Rev Oncol Hematol (2005) 1.04

What have we learned about primary liver transplantation under tacrolimus immunosuppression? Long-term follow-up of the first 1000 patients. Ann Surg (1999) 1.02

Comparison of de novo tumours after liver transplantation with incidence rates from Italian cancer registries. Dig Liver Dis (2009) 1.01

De novo malignancies following liver transplantation: a case-control study with long-term follow-up. Clin Transplant (2006) 0.99

Comparative epidemiologic study of premalignant and malignant epithelial cutaneous lesions developing after kidney and heart transplantation. J Am Acad Dermatol (1995) 0.98

Risk factors associated with the development of skin cancer after liver transplantation. Liver Transpl (2002) 0.97

Immunosuppressive treatment after solid organ transplantation and risk of post-transplant cutaneous squamous cell carcinoma. Nephrol Dial Transplant (2009) 0.96

Non-lymphoid cancer after liver transplantation. Hepatogastroenterology (1997) 0.94

Skin cancer following transplantation: the Israel Penn International Transplant Tumor Registry experience. Transplant Proc (2005) 0.93

Skin cancer education in transplant recipients. Prog Transplant (2008) 0.89

Nonmelanoma skin cancer after liver transplantation. Study of risk factors. Liver Transpl (2005) 0.88

Head and neck cancer in transplant recipients. Curr Opin Otolaryngol Head Neck Surg (2004) 0.87

Cancer in the immunosuppressed organ recipient. Transplant Proc (1991) 0.83

Causes and predisposing factors of de novo tumors in our series of liver transplant recipients. Transplant Proc (2009) 0.82

Skin lesions in adult liver transplant recipients: a study of 100 consecutive patients. Br J Dermatol (2006) 0.82

Recurrent nonhepatic and de novo malignancies after liver transplantation. Transplantation (2009) 0.81

Posttransplant malignancy and newer immunosuppressive protocols after liver transplantation. Transplant Proc (1996) 0.80